Pacific Biosciences of Californi (PACB) Preview For Upcoming Quarterly Earnings
Pacific Biosciences of Californi (NASDAQ:PACB) is anticipated to report earnings Unknown at time of writing
Pacific Biosciences of California, Inc., a development stage company, develops, manufactures, and markets an integrated platform for genetic analysis. The company was founded in 2000 and is headquartered in Menlo Park, California. Pacific Biosciences of Californi trades an average of 506,000 shares per day and has a marketcap of $246 Million.
52 Week High: $16.85
52 Week Low: $2.25
Float Short: 6.75%
Revenue year-over-year has increased to $1.67 million for 2010 vs. $0.14 million for 2009. The bottom line has falling earnings year-over-year of $-140.17 million for 2010 vs. $-87.70 million for 2009.The company's earnings before interest and taxes are falling with an EBIT year-over-year of $-140.23 million for 2010 vs. $-88.07 million for 2009.
Here is a look at the fiscal year revenue. 
The total short interest number of shares for PACB 
The number of days to cover short interest based on average daily trading volume for PACB 
Thank you for reading my article. Please also feel free to share your thoughts and comments.
I use a proprietary blend of technical analysis, financial crowd behavior, and fundamentals in my short-term trades, and while not totally the same in longer swing trades to investments, the concepts used are similar. You may want to use this article as a starting point of your own research with your financial planner. I use Seeking Alpha, Edgar Online, and Yahoo Finance for most of my data. I use the confirmed symbols from earnings.com that I believe to be of the most interest.
